Owens & Minor - OMI STOCK NEWS

Owens & Minor (NYSE: OMI) is set to release its financial results for Q4 and the full year of 2020 on February 24, 2021, before the NYSE opens. A conference call will follow at 8:30 a.m. ET for investors to discuss the results. Participants can access the call via phone or through a webcast available on their Investor Relations website. With over 15,000 employees, Owens & Minor is a leading global healthcare solutions provider focused on delivering value across the healthcare industry.

Owens & Minor (OMI) welcomes President Biden's National Strategy for COVID-19 Response. CEO Edward Pesicka emphasizes the importance of using American-made PPE during the pandemic. In 2020, the company achieved over 12 billion PPE units delivered in the U.S., with significant increases in production: 1000% for N95s, nearly 100% for surgical masks, over 600% for face shields, and 300% for isolation gowns. Owens & Minor has made substantial investments in manufacturing efficiency and was selected to produce 600 million N95 respirators for the U.S. market, showcasing its capabilities and commitment to pandemic response.

Owens & Minor (NYSE: OMI) announced its participation in the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021. President and CEO Ed Pesicka will present at 10:50 AM ET, with the session available for live webcast and subsequent replay on the company's website for 30 days. With over 15,000 employees across 70 countries, Owens & Minor is a global healthcare solutions provider focused on optimizing supply chain performance and financial outcomes for healthcare providers and manufacturers.

Owens & Minor, Inc. (NYSE: OMI) will participate in the BofA Securities 2020 Leveraged Finance Conference on December 1, 2020. Andy Long, Executive Vice President and CFO, will present at 7:30 AM ET. The presentation can be accessed live via webcast on the company's website. This event aligns with Owens & Minor's commitment to delivering healthcare solutions globally, supported by over 15,000 employees in 70 countries. The webcast will also be archived for 30 days, ensuring ongoing accessibility for interested investors.

Owens & Minor (NYSE: OMI) is ramping up the production of medical-grade facial protection products in response to the ongoing COVID-19 pandemic and approaching flu season. The company reported a greater than 1000% increase in N95 respirator production and nearly 100% increase in surgical and procedure masks through capital investments and operational efficiencies. They have established an end-to-end supply chain for manufacturing these products in the Americas, setting themselves apart from other suppliers reliant on Asia.

Owens & Minor (NYSE: OMI) will participate in the 29th Annual Credit Suisse Healthcare Conference on November 12, 2020. The event will feature a fireside chat led by President and CEO Ed Pesicka, starting at 10:15 AM ET. This discussion, aimed at analysts and investors, will be available for live streaming on the company’s website. The archived webcast will be accessible for 30 days post-event. Founded in 1882, Owens & Minor is a global healthcare solutions provider, serving customers in 70 countries.

Owens & Minor reported strong third-quarter results for 2020, with revenue reaching $2,188 million, down from $2,293 million in Q3 2019. The company achieved an adjusted net income of $49 million, reflecting a 250% increase in adjusted net income per share to $0.81. Operating cash flow was $118 million, and total debt was reduced by $70 million in the quarter. Looking ahead, Owens & Minor expects adjusted net income per share for 2020 to be between $1.90 and $2.00, indicating a focus on growth with a positive outlook for double-digit earnings growth in 2021.

Owens & Minor (NYSE: OMI) will announce its third quarter financial results on November 2, 2020, post-market. A conference call to discuss the results is scheduled for the same day at 5:00 p.m. ET, accessible via phone or a webcast through their Investor Relations section. With over 15,000 employees, Owens & Minor operates globally and focuses on healthcare solutions that enhance supply chain efficiency and financial performance for providers and manufacturers.

Owens & Minor, Inc. (NYSE: OMI) priced its public offering of 8,475,000 shares at $20.50 each, aiming for approximately $173.7 million in gross proceeds. The underwriters have the option to purchase an additional 1,271,250 shares. The company plans to utilize the majority of the net proceeds to repay debt, with remaining funds allocated for general corporate purposes. The closing date is expected on October 6, 2020, pending customary conditions. The offering falls under a shelf registration statement filed with the SEC.